Identification of Sentinel Lymph Node Macrometastasis in Breast Cancer by Deep Learning Based on Clinicopathological Characteristics

Overview

Journal Sci Rep

Specialty Science

Date 2024 Nov 6

PMID 39505964

Authors

Daqu Zhang

Miriam Svensson

Patrik Eden

Looket Dihge

Affiliations

Soon will be listed here.

Abstract

The axillary lymph node status remains an important prognostic factor in breast cancer, and nodal staging using sentinel lymph node biopsy (SLNB) is routine. Randomized clinical trials provide evidence supporting de-escalation of axillary surgery and omission of SLNB in patients at low risk. However, identifying sentinel lymph node macrometastases (macro-SLNMs) is crucial for planning treatment tailored to the individual patient. This study is the first to explore the capacity of deep learning (DL) models to identify macro-SLNMs based on preoperative clinicopathological characteristics. We trained and validated five multivariable models using a population-based cohort of 18,185 patients. DL models outperform logistic regression, with Transformer showing the strongest results, under the constraint that the sensitivity is no less than 90%, reflecting the sensitivity of SLNB. This highlights the feasibility of noninvasive macro-SLNM prediction using DL. Feature importance analysis revealed that patients with similar characteristics exhibited different nodal status predictions, indicating the need for additional predictors for further improvement.

References

Rakha E, Ellis I . An overview of assessment of prognostic and predictive factors in breast cancer needle core biopsy specimens. J Clin Pathol. 2007; 60(12):1300-6. PMC: 2095575. DOI: 10.1136/jcp.2006.045377. View

Barranger E, Coutant C, Flahault A, Delpech Y, Darai E, Uzan S . An axilla scoring system to predict non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement. Breast Cancer Res Treat. 2005; 91(2):113-9. DOI: 10.1007/s10549-004-5781-z. View

. Effect of mammographic service screening on stage at presentation of breast cancers in Sweden. Cancer. 2007; 109(11):2205-12. DOI: 10.1002/cncr.22671. View

Yang J, Wang T, Yang L, Wang Y, Li H, Zhou X . Preoperative Prediction of Axillary Lymph Node Metastasis in Breast Cancer Using Mammography-Based Radiomics Method. Sci Rep. 2019; 9(1):4429. PMC: 6418289. DOI: 10.1038/s41598-019-40831-z. View

Saerens M, Latinne P, Decaestecker C . Adjusting the outputs of a classifier to new a priori probabilities: a simple procedure. Neural Comput. 2001; 14(1):21-41. DOI: 10.1162/089976602753284446. View

Reimer T . Omission of axillary sentinel lymph node biopsy in early invasive breast cancer. Breast. 2023; 67:124-128. PMC: 9982316. DOI: 10.1016/j.breast.2023.01.002. View

Marme F, Krieghoff-Henning E, Gerber B, Schmitt M, Zahm D, Bauerschlag D . Deep learning to predict breast cancer sentinel lymph node status on INSEMA histological images. Eur J Cancer. 2023; 195:113390. DOI: 10.1016/j.ejca.2023.113390. View

Wang L, Li J, Qiao J, Guo X, Bian X, Guo L . Establishment of a model for predicting sentinel lymph node metastasis in early breast cancer based on contrast-enhanced ultrasound and clinicopathological features. Gland Surg. 2021; 10(5):1701-1712. PMC: 8184381. DOI: 10.21037/gs-21-245. View

Wang J, Yang X, Cai H, Tan W, Jin C, Li L . Discrimination of Breast Cancer with Microcalcifications on Mammography by Deep Learning. Sci Rep. 2016; 6:27327. PMC: 4895132. DOI: 10.1038/srep27327. View

10.

Bevilacqua J, Kattan M, Fey J, Cody 3rd H, Borgen P, Van Zee K . Doctor, what are my chances of having a positive sentinel node? A validated nomogram for risk estimation. J Clin Oncol. 2007; 25(24):3670-9. DOI: 10.1200/JCO.2006.08.8013. View

11.

Svensson M, Dihge L . The Role of Surgical Axillary Staging Prior to Immediate Breast Reconstruction in the Era of De-Escalation of Axillary Management in Early Breast Cancer. J Pers Med. 2022; 12(8). PMC: 9410323. DOI: 10.3390/jpm12081283. View

12.

Steinhof-Radwanska K, Lorek A, Holecki M, Barczyk-Gutkowska A, Grazynska A, Szczudlo-Chrascina J . Multifocality and Multicentrality in Breast Cancer: Comparison of the Efficiency of Mammography, Contrast-Enhanced Spectral Mammography, and Magnetic Resonance Imaging in a Group of Patients with Primarily Operable Breast Cancer. Curr Oncol. 2021; 28(5):4016-4030. PMC: 8534697. DOI: 10.3390/curroncol28050341. View

13.

Mariscotti G, Houssami N, Durando M, Bergamasco L, Campanino P, Ruggieri C . Accuracy of mammography, digital breast tomosynthesis, ultrasound and MR imaging in preoperative assessment of breast cancer. Anticancer Res. 2014; 34(3):1219-25. View

14.

Yala A, Lehman C, Schuster T, Portnoi T, Barzilay R . A Deep Learning Mammography-based Model for Improved Breast Cancer Risk Prediction. Radiology. 2019; 292(1):60-66. DOI: 10.1148/radiol.2019182716. View

15.

Zhao Y, Liu Y, Xie S, Jiang Y, Shao Z . A Nomogram Predicting Lymph Node Metastasis in T1 Breast Cancer based on the Surveillance, Epidemiology, and End Results Program. J Cancer. 2019; 10(11):2443-2449. PMC: 6584352. DOI: 10.7150/jca.30386. View

16.

Danaee P, Ghaeini R, Hendrix D . A DEEP LEARNING APPROACH FOR CANCER DETECTION AND RELEVANT GENE IDENTIFICATION. Pac Symp Biocomput. 2016; 22:219-229. PMC: 5177447. DOI: 10.1142/9789813207813_0022. View

17.

Krag D, Anderson S, Julian T, Brown A, Harlow S, Ashikaga T . Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol. 2007; 8(10):881-8. DOI: 10.1016/S1470-2045(07)70278-4. View

18.

Vrdoljak J, Boban Z, Baric D, Segvic D, Kumric M, Avirovic M . Applying Explainable Machine Learning Models for Detection of Breast Cancer Lymph Node Metastasis in Patients Eligible for Neoadjuvant Treatment. Cancers (Basel). 2023; 15(3). PMC: 9913601. DOI: 10.3390/cancers15030634. View

19.

Chung A, Gangi A, Amersi F, Zhang X, Giuliano A . Not Performing a Sentinel Node Biopsy for Older Patients With Early-Stage Invasive Breast Cancer. JAMA Surg. 2015; 150(7):683-4. DOI: 10.1001/jamasurg.2015.0647. View

20.

Galimberti V, Cole B, Viale G, Veronesi P, Vicini E, Intra M . Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial. Lancet Oncol. 2018; 19(10):1385-1393. DOI: 10.1016/S1470-2045(18)30380-2. View